Clinical Trial Update: Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study evaluating a non-calcium based phosphate binder and its effect on FGF23 levels in chronic kidney disease; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Investigational non-calcium based phosphate binder

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Chronic Kidney Disease | EARLY_Phase 1 | Status: COMPLETED